Stock listing

NASDAQ:OMED OncoMed Pharmaceuticals Inc Stock

Follow OncoMed Pharmaceuticals Inc into a list and get an email when it puts out news.

Last close · NASDAQ:OMED

$0.89 USD

Close on Apr 23, 2019 · No longer trades

Jul 18, 2013 to last close -96.7% · weekly closes, Jul 18, 2013 – Apr 23, 2019
Lowest – highest close
$0.566 – $38.01 USDSince Jul 18, 2013 · lowest Dec 24, 2018 · highest Feb 25, 2014

Delisted NASDAQ:OMED no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.

Ticker
NASDAQ:OMED
Asset type
Stock
Exchange
NASDAQ
Currency
USD

OncoMed Pharmaceuticals Inc on 6ix

Decks
5 decks · latest Mar 12, 2019

Decks

DeckKindSlidesDate
Merger or Acquisition (March 2019)Merger or acquisition19 slidesMar 12, 2019
Merger or Acquisition (February 2019)Merger or acquisition57 slidesFeb 12, 2019
Merger or Acquisition (February 2019)Merger or acquisition57 slidesFeb 11, 2019
Merger or Acquisition (December 2018)Merger or acquisition61 slidesDec 11, 2018
Merger or Acquisition (December 2018)Merger or acquisition12 slidesDec 6, 2018

Open Decks

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
William Waddill
Other companies: Annexon, Inc. (LEAD INDEPENDENT DIRECTOR · Since at least Aug 12, 2021); Arrowhead Pharmaceuticals, Inc. (Director · Since at least Dec 20, 2017); Protagonist Therapeutics, Inc. (Independent Director · Since at least Aug 10, 2016); Turnstone Biologics Corp. (Director · Apr 15, 2024 – Jun 3, 2024 · Past); Calithera Biosciences, Inc. (SR. VP & CFO · Oct 1, 2014 – Nov 29, 2016 · Past)
SVP & Chief Financial Officer · Jul 17, 2013 – Jul 23, 2013 · Past
Terry P Gould
Other companies: Icosavax Inc (Director · Jul 28, 2021 – Aug 2, 2021 · Past); Aptinyx Inc (Director · Jun 20, 2018 – May 26, 2022 · Past); Corvus Pharmaceuticals, Inc. (Director · Mar 22, 2016 – Jun 13, 2024 · Past)
Director · Jul 17, 2013 – Jun 22, 2016 · Past
Alicia J Hager
Other companies: Nkarta, Inc. (Chief Legal Officer · Oct 26, 2020 – Jan 15, 2025 · Past)
SVP and General Counsel · Oct 7, 2017 – Apr 23, 2019 · Past
Yvonne Li
Other companies: Senti Biosciences Holdings, Inc. (Interim CFO · May 4, 2024 – May 4, 2024 · Past)
See Remarks · Mar 16, 2018 – Apr 23, 2019 · Past

Open People

Log in to ask 6ix AI your own questions about OncoMed Pharmaceuticals Inc.